Emily Whelan

Ms. Whelan's practice includes Patent Office practice, litigation, and counseling in the field of life sciences, including chemistry, biotechnology and pharmaceuticals. Her experience includes patent strategy across the spectrum from pre-litigation investigation and litigation, to Patent Office post-grant proceedings including inter partes review and reexamination, to analysis of the competitive landscape and IP due diligence, as well as obtaining patent protection and portfolio management.

Practice highlights include being part of teams involved in:

-Representing innovator pharmaceutical companies in ANDA, biosimilars, and other patent litigation involving pharmaceutical and biotechnology patents;

-Inter partes review of patents in pharmaceutical and semiconductor fields;

-Patent prosecution and reexamination of patents in chemical technologies, including new battery materials;

-IP due diligence and analysis of competitor patents in pharmaceutical, biotechnology, medical device and food industries; and

-Managing patent portfolios including small molecules, pharmaceutical formulations, and treatment methods for pharmaceutical companies.

Ms. Whelan is Past President (2024–2025) of the Boston Intellectual Property Law Association. Ms. Whelan is also a member of the PTAB Bar Association.